Pharma Equity Group

0.37DKK -4.15 %

HC Andersen Capital receives payment from Pharma Equity Group for a DigitalIR/Corporate Visibility agreement. See disclaimer.

9 investors are following this company

Pharma Equity Group is an investment company. The company is an owner and manager of a portfolio of growth companies around the global market, where the investment is mainly found in the life science sector. The vision is to create long-term returns and to drive business development within each investment, mainly via greater ownership and board representation. The company was founded in 2002 and has its headquarters in Copenhagen.

Revenue
-
EBIT %
-
P/E
1.95
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Copenhagen
PEG
Daily low / high price
0.36 / 0.37 DKK
Market cap
378.5M DKK
Turnover
13.74K DKK
Volume
38K

Financial calendar

Publisher
Life Science Seminar – Wrap up from our event last week – Thursday the 31st. of August.

Life Science Seminar – Wrap up from our event last week – Thursday the 31st. of August.

Analyst Comment05.09.2023 by Henrik Ekman, Claus Thestrup
Publisher
Fireside chat - Pharma Equity Group - One pager

HC Andersen Capital - Interview med senior analytiker Henrik Ekman. Vi gennemgår vores seneste One-pager på Pharma Equity Group.

Analyst Comment15.06.2023 by Claus Thestrup, Henrik Ekman
Settlement - Purchase of shares

Regulatory press release02.06.2023
Publisher
Pharma Equity Group - (One Pager): Initiation of the company

Learn more about PEG (Pharma Equity Group) and its first investment Reponex. Read this 1-pager.

Research30.05.2023 by Claus Thestrup, Henrik Ekman
Managers’ transactions

Regulatory press release25.05.2023
Publisher
Interview med CEO Thomas K. Selsø fra Pharma Equity Group - Hvad skete der i 1. kvartal?

Interview med CEO Thomas K. Selsø fra Pharma Equity Group - Hvad skete der i 1. kvartal?

Analyst Comment15.05.2023 by Claus Thestrup
Publisher
Introduktion til nyt dansk biotekselskab Pharma Equity Group

Pharma Equity Group vælger en anden vej ind på børsen og har primært fokus på partnerskabsaftaler. Mød den kommende adm. direktør Thomas Selsø samt kommende bestyrelseformand Peter Mørch Eriksen i det nye danske biotekselskab Pharma Equity Group A/S.

Analyst Comment06.03.2023 by Claus Thestrup